Published in

American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 6(53), p. 2696-2699, 2009

DOI: 10.1128/aac.01297-08

Links

Tools

Export citation

Search in Google Scholar

High Rate of Reduced Susceptibility to Ciprofloxacin and Ceftriaxone among Nontyphoid Salmonella Clinical Isolates in Asia

Journal article published in 2009 by Hao-Yuan Lee, 蘇玲慧;蔡明翰;薛博仁;劉建衛;邱政洵, Ming-Han Tsai, Lin-Hui;Tsai Ming-Han;Hsueh Po-Ren;Liu Jien-Wei;Chiu Cheng-Hsun Su, Shin-Woo Kim ORCID, Hyun-Ha Chang, Sook-In Jung, Kyung-Hwa Park, Jennifer Perera, Celia Carlos, Ban Hock Tan, H. T. Ban, Gamini Kumarasinghe, Thomas So, Anan Chongthaleong and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Orange circle
Published version: archiving restricted
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

This multinational study from Asia revealed that reduced susceptibility to ciprofloxacin (MIC, 0.125 to 1 mu g/ml) in nontyphoid Salmonella isolates was common in Taiwan (48.1%) and Thailand (46.2%) and in S. enterica serotype Choleraesuis (68.8%) and S. Virchow (75.0%) from all countries. Reduced susceptibility to ceftriaxone (MIC, 2 to 8 mu g/ml) remained uncommon in Asia, except in Taiwan (38.0 %) or in S. Typhimurium (25.0%) from all countries. ; 醫學系檢驗醫學科 ; 醫學系 ; 醫學院 ; 期刊論文